PND25 ECONOMIC EVALUATION OF NATALIZUMAB IN THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN 4 EUROPEAN COUNTRIES
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72606-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)72606-7/fulltext
Title :
PND25 ECONOMIC EVALUATION OF NATALIZUMAB IN THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN 4 EUROPEAN COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72606-7&doi=10.1016/S1098-3015(11)72606-7
First page :
A392
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
765